Skip to main content
    N

    Neurosense Therapeutics Ltd (NRSN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.51
    -0.06 (-3.51%)

    Market Cap: $3.21M

    Last updated: Nov 17, 2026 at 4:00 PM ET

    Neurosense Therapeutics Ltd (NRSN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Neurosense Therapeutics (NRSN) closed at $1.51 on Nov 17, 2026, 94.1% below its 52-week high of $25.40. Its price fell 92.3% over the past 12 months. The month-end price fell 78.4% over the 3 years through Oct 2026, a compound annual decline of 40.0%.

    Price Chart

    From Dec 2021 to Oct 2026, its highest month-end close was $79.40 in Mar 2022 and its lowest $1.99 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NRSN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NRSN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 81.0%, and over 6 months it fell 90.1%.

    PeriodChange
    1 month-43.3%
    3 months-81.0%
    6 months-90.1%
    12 months-92.3%
    12 months, with dividends-92.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-78.4%-40.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 52.9%, and its weakest was 2022, when it fell 50.4%.

    YearCloseChange
    2026 through Oct 2026$1.99-87.1%
    2025$15.38-35.9%
    2024$24.00+52.9%
    2023$15.70-35.7%
    2022$24.40-50.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 60.6% below its 50-day average of $3.83 and 87.2% below its 200-day average of $11.83.

    MeasureValuePrice vs
    Close (Nov 17, 2026)$1.51
    52-week high$25.40-94.1%
    52-week low$1.10+37.3%
    50-day average$3.83-60.6%
    200-day average$11.83-87.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.4%.

    MeasureValue
    1-year beta1.62
    Largest fall, 1 year-94.8%
    Largest fall, 3 years-97.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NRSN

    What is NRSN's 1-year price change?

    Neurosense Therapeutics's price fell 92.3% over the past 12 months. With dividends included, the 12-month total return was -92.3%.

    How has NRSN stock done over the long term?

    Neurosense Therapeutics's month-end price fell 78.4% over the 3 years through Oct 2026, a compound annual decline of 40.0%. These figures leave out dividends.

    What is NRSN's 52-week high and low?

    Neurosense Therapeutics's 52-week high is $25.40 and its 52-week low is $1.10. Its close of $1.51 on Nov 17, 2026 is 94.1% below the high.

    What is NRSN's beta?

    Neurosense Therapeutics's 1-year beta against the S&P 500 is 1.62, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 94.8%.

    Is the NRSN chart free?

    Yes. Advanced Charting for NRSN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.